SEC Form 4 · accession 0001144204-16-140449
Neurotrope, Inc. · NTRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Robert Weinstein
Officer — See Remarks
Period of report
Dec 20, 2016
Accepted (ET)
Dec 20, 2016 · 12:40 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001513856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Dec 20, 2016 | X | 41,667 | $0.01 | A | 84,771 | D | |
| Common Stock | Dec 20, 2016 | X | 41,667 | $0.01 | A | 126,438 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Series A Warrant | $0.01 | Dec 20, 2016 | X | 41,667 | D | Nov 13, 2015 | Nov 13, 2020 | Common Stock | 41,667 | 0 | D |
| Series C Warrant | $0.01 | Dec 20, 2016 | X | 41,667 | D | Nov 13, 2015 | Nov 13, 2020 | Common Stock | 41,667 | 0 | D |
Remarks
Chief Financial Officer, Executive Vice President, Treasurer and Secretary